Following participation in these educational activities, you will be able to:
- Discuss the importance of timely treatment of type 2 diabetes and its impact on patient health and outcomes.
- Compare the efficacy and safety profiles of once weekly GLP-1RAs.
- Explain the next generation of GLP-1RAs including the mode of absorption, mechanism of action, dosing schedule, pharmacokinetic/pharmacodynamic properties, glycemic/weight loss efficacy and safety.
These learning activities are suitable for, but not limited to, diabetes specialists, primary care physicians, specialist diabetes nurses, cardiologists, and all other healthcare professionals interested in the treatment of type 2 diabetes.
The English version of the webcast ”The continuing evolution of GLP-1RAs”, is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists.
Each medical specialist should claim only those credits that he/she actually spent in the educational activity. The EACCME is an institution of the European Union of Medical Specialists (UEMS). Only those e-learning materials that are displayed on the UEMSEACCME website have formally been accredited.
Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
This program is made possible thanks to an independent educational grant from Novo Nordisk A/S.
Springer Healthcare IME
The Campus, 4 Crinan Street
London, N1 9XW, UK